Exosomal lncRNA SNHG12 promotes angiogenesis and breast cancer progression Yan ChenYuxin ZhouWeizhu Wu Original Article Open access 04 June 2024
Comparison of water- vs. land-based exercise for improving functional capacity and quality of life in patients living with and beyond breast cancer (the AQUA-FiT study): a randomized controlled trial E. Mur-GimenoM. CollR. Sebio-García Original Article 30 May 2024
Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies Chiara BelliniFrancesca PuglieseJacopo Nori Original Article 29 May 2024
A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database Lizhi TengJuntong DuWeiyang Tao Original Article Open access 27 May 2024
Assessing the effectiveness of high frequency repetitive transcranial magnetic stimulation for post-mastectomy pain in breast cancer patients: A randomized controlled trial Monika KatariaNishkarsh GuptaRenu Bhatia Original Article 26 May 2024
A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy Hiromi OkuyamaFuka TakadaSeigo Nakamura Original Article 26 May 2024
Antitumor effects of co-treatment of resveratrol with antitumor drugs in ER- and HER2-positive breast cancer cells are due to induction of apoptosis and modulation of estrogen receptor expression Beatriz Tinoco FranceschiPatrícia Heloise Alves BezerraMaria Regina Torqueti Original Article 23 May 2024
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype Pascal JézéquelHamza LaslaMario Campone Original Article 22 May 2024
Not all patients with premenopausal breast cancer will experience the negative effects of tamoxifen treatment on their bone mineral density Kadri Altundag Letter to the Editor 18 May 2024
Resilience’s impact on quality of life and post-traumatic growth in breast cancer patients during treatment Songül DuranUmut VarolAhmet Hakan Soytürk Original Article Open access 17 May 2024
Correction: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment Yutaka YamamotoChikako YamauchiShigehira Saji Correction Open access 12 May 2024
Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients Yong-qiang BaoTeng-hua YuChun-ling Jiang Original Article Open access 05 May 2024
Real-world data of HER2-negative early breast cancer patients treated with anthracycline and/or taxane regimens in Japan Akihiko ShimomuraYasuaki SagaraShigehira Saji Original Article Open access 29 April 2024
Adverse effects of tamoxifen treatment on bone mineral density in premenopausal patients with breast cancer: a systematic review and meta-analysis Soo Jin LeeChihwan David ChaMin Sung Chung Original Article 27 April 2024
Percutaneous ultrasound-guided cryoablation for early-stage primary breast cancer: a follow-up study in Japan Hisanori KawamotoKoichiro TsugawaMamoru Fukuda Original Article Open access 27 April 2024
Perspectives for the clinical application of ctDNA analysis to breast cancer drug therapy Tetsuhiro Yoshinami Special Feature 23 April 2024
Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors Pei-Jing YangEing-Mei TsaiTsu-Nai Wang Original Article 23 April 2024
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients Kadri Altundag Letter to the Editor 22 April 2024
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database Yuhang ShangXuelian WangBaoliang Guo Original Article Open access 21 April 2024
Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status Sei NaMilim KimSo Yeon Park Original Article Open access 21 April 2024
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study Tetsuhiro YoshinamiShigenori E. NagaiNorikazu Masuda Original Article Open access 20 April 2024
French national survey on breast cancer care: caregiver and patient views Christine Rousset-JablonskiBarbara LortalAlain Toledano Original Article Open access 18 April 2024
PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer Huan-ping ZhangRui-yuan JiangXiao-jia Wang Review Article Open access 17 April 2024
The usefulness of artificial intelligence in breast reconstruction: a systematic review Karla C. MaitaFrancisco R. AvilaAntonio Jorge Forte Review Article 15 April 2024
Inter- and intra-observer variability of qualitative visual breast-composition assessment in mammography among Japanese physicians: a first multi-institutional observer performance study in Japan Yoichi KoyamaKazuaki NakashimaTakayoshi Uematsu Original Article 15 April 2024
Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study Peter J. K. TokudaTakamasa Mitsuyoshithe Kyoto Radiation Oncology Study Group Original Article Open access 12 April 2024
Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases Alexandre De MouraDelphine LoiratAlexandre Acramel Original Article Open access 10 April 2024
Association between quality of life and mortality risk in patients with breast cancer: a systematic review and meta-analysis Katsuyoshi SuzukiShinichiro MorishitaTakuya Fukushima Review Article 09 April 2024
Nipple–areolar complex malposition in breast reconstruction after nipple-sparing mastectomy: a multi-institutional retrospective observational study in Japan Sayuri KatoHiroki Morithe Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society Original Article 08 April 2024
Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from microarray data from fresh-frozen to FFPE tissues Akira WatanabeRyo TsunashimaYasuto Naoi Original Article 08 April 2024
The influence of a previous implant-based breast reconstruction on postoperative sensation of the deep inferior epigastric artery perforator flap Joep A. F. van RooijEnnie BijkerkStefania M. H. Tuinder Original Article Open access 06 April 2024 Pages: 456 - 466
The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition Michio YoshimuraChikako YamauchiShigehira Saji Special Article Open access 05 April 2024 Pages: 347 - 357
Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy Hiroko NogiAkiko OgiyaThe Collaborative Study Group of Scientific Research of The Japanese Breast Cancer Society Original Article Open access 04 April 2024 Pages: 507 - 518
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment Yutaka YamamotoChikako YamauchiShigehira Saji Special Article Open access 03 April 2024 Pages: 340 - 346
Associations of pre-diagnosis physical activity with treatment tolerance and treatment efficacy in breast cancer patients with neoadjuvant chemotherapy Dan LinKathleen M. SturgeonCheryl L. Thompson Original Article 02 April 2024 Pages: 519 - 528
The correlation study between TOP2A gene expression in circulating tumor cells and chemotherapeutic drug resistance of patients with breast cancer Jin-hui YeJian YuYue-mei Mo Original Article Open access 01 April 2024 Pages: 417 - 425
Prospects for liquid biopsy using microRNA and extracellular vesicles in breast cancer Takahiro OchiyaKazuki HashimotoAkihiko Shimomura Special Feature Open access 30 March 2024
Prognosis of primary breast salivary gland-type carcinoma: a propensity score-matching analysis with invasive carcinoma of no special type based on the SEER database for years 2010–2020 Ewe Seng Ch’ng Original Article 28 March 2024 Pages: 496 - 506
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer Kazutaka NaruiToshihiko SatakeItaru Endo Original Article 21 March 2024 Pages: 476 - 484
Liquid biopsy using non-coding RNAs and extracellular vesicles for breast cancer management Kazuki HashimotoTakahiro OchiyaAkihiko Shimomura Special Feature 21 March 2024
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer Kim VoColton LadburyArya Amini Original Article Open access 20 March 2024 Pages: 485 - 495
Liquid biopsy for breast cancer and other solid tumors: a review of recent advances Hirofumi OhmuraFumiyasu HanamuraEishi Baba Special Feature 16 March 2024
The role of the BTLA–HVEM complex in the pathogenesis of breast cancer Xue Hu Review Article 14 March 2024 Pages: 358 - 370
Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile Danbee KangSeri ParkYeon Hee Park Original Article 12 March 2024 Pages: 467 - 475
Enhancing radiosensitivity in triple-negative breast cancer through targeting ELOB Guo LiXinyue LinZhichao Fu Original Article 12 March 2024 Pages: 426 - 439
A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer Kumiko KidaAkimitsu YamadaTakashi Ishikawa Original Article 08 March 2024 Pages: 409 - 416
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan Yasue TsuchidaNaoki NiikuraNaoki Hayashi Original Article 07 March 2024 Pages: 401 - 408
Deep learning model to predict Ki-67 expression of breast cancer using digital breast tomosynthesis Ken ObaMaki AdachiHiroko Tsunoda Special Feature 07 March 2024
Reply to comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al. Reiko FukuiTakahiro WatanabeYasuo Miyoshi Letter to the Editor 04 March 2024 Pages: 536 - 538
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines Masaya HattoriNaoko HonmaYutaka Yamamoto Special Article Open access 04 March 2024 Pages: 335 - 339